Stockreport

Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant [Yahoo! Finance]

Forte Biosciences, Inc.  (FBRX) 
PDF DB107 is a proprietary gene therapy platform for the treatment of patients with newly diagnosed high grade glioma Anova helped secure $11.8m CIRM funding, and will ma [Read more]